Global Spatial Omics Solutions Market

Report ID : 1352 | Published : 2022-08-24 | Pages: 179 | Format: PDF/EXCEL

The Global Spatial Omics Solutions Market size was valued at US$ 232.6 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.18% from 2022 to 2030. Spatial omics consists of Proteomics, epigenomics, transcriptomics, Genomics, metabolomics and lipidomic. The field of spatial omics combines molecular analysis with geographical information concerning the location of a cell inside a tissue. As a result, this technology provides a powerful instrument for studying essential phenomena such as tissue organization and cell regulation. The spatial profiling-based techniques permit the analysis of the tissue microenvironment and the tumour's biology, and it is also possible to evaluate the tissue biomarkers. All The fields of Spatial omics have gained prominence in recent years as neurological ailments, and rare diseases have become more widespread worldwide. More than one hundred mRNAs from a single formalin-fixed paraffin-embedded (FFPE) tissue or frozen tissue section are currently being developed by several contract research organizations using spatial profiling-based services. This development will allow for simultaneous in-situ spatial analysis of multiple biomarker proteins.

The increasing prevalence of a wide variety of genetic disorders, global technological advancements in sequencing technologies, and an increase in research funding in spatial omics are all factors driving the market. Increases in the use of spatial OMICS in drug discovery and development, as well as the growth potential of spatial OMICS as a tool for diagnosing cancer, are expected to drive growth in the market for spatial OMICS. Spatial transcriptomics is progressively displaying potential for resolving the constraints of both bulk and single-cell RNA sequencing through the utilization of spatially barcoded microarray probes to capture and sequence mRNA from frozen tissue sections. In the summer of 2022, Bruker Corporation revealed a slew of advancements for spatial multiomics, emphasizing unbiased Spatial Single-Cell Metabolomics (SSCM), a technique that uses the metabolic signature of tissues and individual cells to look for differences in cell phenotypes.

High capital requirements, which hinder the expansion of global reach, and a lack of tools for computational analysis are the two primary factors contributing to market restraints. Also, many factors could limit the market's growth, including a shortage of experienced professionals and a lack of awareness of modern spatial-based technology.

The Spatial Omics market is segmented by solution type, sample analyzed, application and end-user. All of these segments are subdivided into respective segments. The solution type segment has instruments, consumables and services, respectively. The sample analyzed category comprises DNA, RNA, and Protein samples. Also, the application segment includes diagnosis, translation research, drug discovery and development, single cell analysis, cell biology and other applications. The last segment is the end-user segment which contains Academic and Research Institutions, Biopharmaceutical and Biotechnological Companies, Contract Research Organizations and other end-users.

North America has the highest share of the spatial omics market because of improving healthcare infrastructure, rising per capita income, and the availability of state-of-the-art research laboratories and institutes in the area.

The Prominent key player list contains Standard BioTools (Fluidigm Corporation), 10x Genomics, Inc., Bruker, Canopy Biosciences, NanoString Technologies, Inc., Bio-Techne Corporation, Flagship Biosciences, Inc, Akoya Biosciences, Inc., Rebus Biosystems, BioSpyder Technologies, S2 Genomics, Inc., IONpath, Inc., Miltenyi Biotec, RareCyte, Inc., Visikol, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., Fluidigm Corporation, Genomic Vision, Seven Bridges Genomics, Resolve Biosciences, Readcoor, Inc., Lunaphore Technologies, Molecular Machines & Industries (MMI), Dovetail Genomics, Vizgen Corp., Optical Biosystems, Inc., Ultivue, Inc., Cytiva and other key players

  • Fluidigm Corporation
  • 10x Genomics, Inc.
  • Bruker
  • Canopy Biosciences
  • NanoString Technologies, Inc.
  • Bio-Techne Corporation
  • Flagship Biosciences, Inc
  • Akoya Biosciences, Inc.
  • Rebus Biosystems
  • BioSpyder Technologies
  • S2 Genomics, Inc.
  • IONpath, Inc.
  • Miltenyi Biotec
  • RareCyte, Inc.
  • Visikol, Inc.
  • Illumina Inc.
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Genomic Vision
  • Seven Bridges Genomics
  • Resolve Biosciences
  • Readcoor, Inc.
  • Lunaphore Technologies
  • Molecular Machines & Industries (MMI)
  • Dovetail Genomics
  • Vizgen Corp.
  • Optical Biosystems, Inc.
  • Ultivue, Inc.
  • Cytiva

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Spatial Omics Solutions Market Snapshot

Chapter 4. Global Spatial Omics Solutions Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. COVID 19 Impact Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

Chapter 5. Market Segmentation 1: Solution Type Estimates & Trend Analysis

5.1. Solution Type & Market Share, 2022 & 2030

5.2. Market Size (Value) & Forecasts and Trend Analyses, 2022 to 2030 for the following Solution Type:

5.2.1. Instruments

5.2.2. Consumables

5.2.3. Services

Chapter 6. Market Segmentation 2: Sample Analyzed & Trend Analysis

6.1. Sample Analyzed & Market Share, 2022 & 2030

6.2. Market Size (Value)& Forecasts and Trend Analyses, 2022 to 2030 for the following Sample Analyzed:

6.2.1. DNA

6.2.2. RNA

6.2.3. Protein

Chapter 7. Market Segmentation 3: Application & Trend Analysis

7.1. Application & Market Share, 2022 & 2030

7.2. Market Size (Value)& Forecasts and Trend Analyses, 2022 to 2030 for the following Application:

7.2.1. Diagnostics

7.2.2. Translation Research

7.2.3. Drug Discovery and Development

7.2.4. Single Cell Analysis

7.2.5. cell biology

7.2.6. Other Applications

Chapter 8. Market Segmentation 4: End-Users & Trend Analysis

8.1. End-Users & Market Share, 2022 & 2030

8.2. Market Size (Value)& Forecasts and Trend Analyses, 2022 to 2030 for the following End-Users

8.2.1. Academic and Research Institutions

8.2.2. Biopharmaceutical and Biotechnological Companies

8.2.3. Contract Research Organization

8.2.4. Other End Users

Chapter 9. Spatial Omics Solutions Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts Solution Type, 2022-2030

9.1.2. North America Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts by Sample Analyzed, 2022-2030

9.1.3. North America Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts Application, 2022-2030

9.1.4. North America Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts End-Users, 2022-2030

9.1.5. North America Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts by country, 2022-2030

9.1.5.1. U.S.

9.1.5.2. Canada

9.2. Europe

9.2.1. Europe Spatial Omics Solutions Market revenue (US$ Million) Solution Type, 2022-2030

9.2.2. Europe Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts by Sample Analyzed, 2022-2030

9.2.3. Europe Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts Application, 2022-2030

9.2.4. Europe Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts End-Users, 2022-2030

9.2.5. Europe Spatial Omics Solutions Market revenue (US$ Million) by country, 2022-2030

9.2.5.1. Germany

9.2.5.2. Poland

9.2.5.3. France

9.2.5.4. Italy

9.2.5.5. Spain

9.2.5.6. UK

9.2.5.7. Rest of Europe

9.3. Asia Pacific

9.3.1. Asia Pacific Spatial Omics Solutions Market revenue (US$ Million) Solution Type, 2022-2030

9.3.2. Asia Pacific Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts by Sample Analyzed, 2022-2030

9.3.3. Asia Pacific Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts Application, 2022-2030

9.3.4. Asia Pacific Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts End-Users, 2022-2030

9.3.5. Asia Pacific Spatial Omics Solutions Market revenue (US$ Million) by country, 2022-2030

9.3.5.1. China

9.3.5.2. India

9.3.5.3. Japan

9.3.5.4. Australia

9.3.5.5. Rest of Asia Pacific

9.4. Latin America

9.4.1. Latin America Spatial Omics Solutions Market revenue (US$ Million) Solution Type, 2022-2030

9.4.2. Latin America Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts by Sample Analyzed, 2022-2030

9.4.3. Latin America Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts Application, 2022-2030

9.4.4. Latin America Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts End-Users, 2022-2030

9.4.5. Latin America Spatial Omics Solutions Market revenue (US$ Million) by country, 2022-2030

9.4.5.1. Brazil

9.4.5.2. Rest of Latin America

9.5. MEA

9.5.1. MEA Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts Solution Type, 2022-2030

9.5.2. MEA Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts by Sample Analyzed, 2022-2030

9.5.3. MEA Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts Application, 2022-2030

9.5.4. MEA Spatial Omics Solutions Market revenue (US$ Million) estimates and forecasts End-Users, 2022-2030

9.5.5. MEA revenue Spatial Omics Solutions Market revenue (US$ Million) by country, (US$ Million) 2022-2030

9.5.5.1. South Africa

9.5.5.2. Rest of MEA

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Standard BioTools (Fluidigm Corporation)

10.2.2. 10x Genomics, Inc.

10.2.3. Bruker

10.2.4. Canopy Biosciences

10.2.5. NanoString Technologies, Inc.

10.2.6. Bio-Techne Corporation

10.2.7. Flagship Biosciences, Inc

10.2.8. Akoya Biosciences, Inc.

10.2.9. Rebus Biosystems

10.2.10. BioSpyder Technologies

10.2.11. S2 Genomics, Inc.

10.2.12. IONpath, Inc.

10.2.13. Miltenyi Biotec

10.2.14. RareCyte, Inc.

10.2.15. Visikol, Inc.

10.2.16. Illumina Inc.

10.2.17. Bio-Rad Laboratories, Inc.

10.2.18. Fluidigm Corporation

10.2.19. Genomic Vision

10.2.20. Seven Bridges Genomics

10.2.21. Resolve Biosciences

10.2.22. Readcoor, Inc.

10.2.23. Lunaphore Technologies

10.2.24. Molecular Machines & Industries (MMI)

10.2.25. Dovetail Genomics

10.2.26. Vizgen Corp.

10.2.27. Optical Biosystems, Inc.

10.2.28. Ultivue, Inc.

10.2.29. Cytiva

10.2.30. Other Prominent Players

Global Spatial Omics Solutions Market, by Solution Type, 2022-2030 (Value US$ Mn)

  • Instruments
  • Consumables
  • Services 

Global Spatial Omics Solutions Market, by Sample Analyzed, 2022-2030 (Value US$ Mn)

  • DNA
  • RNA
  • Protein

Global Spatial Omics Solutions Market, by Application, 2022-2030 (Value US$ Mn)

  • Diagnostics
  • Translation Research
  • Drug Discovery and Development
  • Single Cell Analysis
  • cell biology
  • Other Applications

Global Spatial Omics Solutions Market, by End-User, 2022-2030 (Value US$ Mn)

  • Academic and Research Institutions
  • Biopharmaceutical and Biotechnological Companies
  • Contract Research Organization
  • Other End Users 

Global Spatial Omics Solutions Market, by Region, 2022-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa 

North America Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Global Spatial Omics Solutions Market?

US$ 232.6 million in 2021

annual growth rate (CAGR) of 11.18% from 2022 to 2030.

Our Clients